Sarfaraz K. Niazi

mRNA Therapeutics (eBook, PDF)

Fast-to-Market Strategies

• Format: PDF

Produktbeschreibung

The paradigm shift during the pandemic now allows us to develop new biologics that were never possible before and find treatments for autoimmune disorders that remain untreatable.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 326
• Erscheinungstermin: 6. Dezember 2022
• Englisch
• ISBN-13: 9781000788068
• Artikelnr.: 66207822

Autorenporträt

Sarfaraz K. Niazi, Ph.D., is an Adjunct Professor at the University of Illinois and the University of Houston; he has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the field of bioprocessing, drug discovery, drug formulations, thermodynamic systems, alcohol aging, nutraceuticals, and treatment of autoimmune diseases. He has hands-on experience establishing biotechnology projects, from concept to market, including FDA approvals. In addition, he has first-hand experience in establishing RNA therapeutic product development and manufacturing, including the mRNA vaccine for COVID-19. He also serves as an advisor to major pharmaceutical and biopharmaceutical companies, regulatory agencies, and many heads of state. He is also a patent law practitioner. Email: [e-mail]

Inhaltsangabe

Background. 1. The Genome Machine. 2. Understanding Nucleic Acids. 3. RNA
Therapeutics. 4. Nucleoside Vaccines. 5. cGMP mRNA Vaccine Manufacturing.
6. Regulatory Guidance. Appendix 1. Covid-19 mRNA Vaccine Manufacturing
Feasibility. Appendix 2. Pharmacopeial Testing. Appendix 3. Suggested
Readings